Laboratorio Chimico Internazionale

Laboratorio Chimico Internazionale (LCI) is a prominent Italian developer and manufacturer of Active Pharmaceutical Ingredients (APIs) for the global pharmaceutical industry. Based in Milan, the company specializes in the production of controlled substances, including treatments for addiction and pain management, as well as APIs for respiratory and cardiovascular indications. LCI provides both generic API production and custom synthesis services (CDMO) to its partners. Since its acquisition by Fabbrica Italiana Sintetici (FIS) in 2016, LCI has operated as a key component of a larger manufacturing network, leveraging its GMP-certified facility in Segrate. The company is known for its technical expertise in complex chemical processes and regulatory compliance.